S. 1414In Committee
Expedited Access to Biosimilars Act
Expand faster market entry for biosimilars by creating an expedited access pathway for those biologic products
Plain-English overview
What this bill does
Expand faster market entry for biosimilars by creating an expedited access pathway for those biologic products
Key points
- Establish expedited biosimilar pathway
Current status
Where it stands
Status
In Committee
Latest action
2025-04-10 — Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Related context
Topics and policy areas
undefinedHealth